Swine

Pig production costs are rising. Labor is tight. Infectious diseases continue to threaten, while market conditions are in constant flux. In the face of these uncertainties, pork producers turn to our global network of swine health experts for effective vaccines and big-picture strategies to sustain their businesses for the long term.

Evolving disease threats affect both pigs and the farmers who raise them. Preventive measures such as vaccination and biosecurity are essential to limit disease spread and secure pig health and animal protein supply. With longstanding experience and leading vaccines, we help farmers keep their pig herds thriving and offer ongoing education and insights on critical swine health and industry issues.

Animal vaccines are a lynchpin of global food security

Did you know that roughly 25% of livestock in developing countries die each year of preventable diseases? And worldwide, uncontrolled disease outbreaks significantly impact the food industry. Let’s take a deep dive into the critical importance of preventive vaccination to ensure food security.

[Find out more](/content/za/disclaimer/bi?path=https%3A%2F%2Fannualreport.boehringer-ingelheim.com%2F2023%2Fmagazine%2Fanimal-health%2Fanimal-vaccines-are-a-lynchpin-of-global-food-security%2Findex.html "Find out more"/index.html)

Recognizing scientific excellence: the European PRRS Research Awards

Every year, we give out the European PRRS Research Awards to fund scientific work on practical methods for battling this serious swine disease. Keep an eye out for the 2025 award winners to be announced in the fall.

[Visit site](/content/za/disclaimer/external?path=https%3A%2F%2Fwww.prrs.com%2Fhow-submit-your-work-european-prrs-research-awards-2025 "Visit site"/index.html)

Keeping 27 billion livestock disease-free is a big responsibility

Protecting the health of cattle, pigs, chickens, and other livestock worldwide protects food supplies, public health, and economic systems. Dr. Armin Wiesler, Head of our Animal Health Business Unit, offers his perspective on these critical issues.

[Find out more](/content/za/disclaimer/market?path=https%3A%2F%2Fwww.boehringer-ingelheim.com%2Fannualreport%2F2024%2Flivestock-animal-disease%2F "Find out more"/index.html)

Biosecurity: a critical measure against African swine fever

While not a danger to human health, the rapid spread and high fatality of African swine fever (ASF) is a major threat to pig health and the economy. As we work to develop a vaccine against this challenging virus, Boehringer provides biosecurity guidance and tools to help protect pigs from ASF and other infectious threats.

[Read more](/content/za/disclaimer/market?path=https%3A%2F%2Fwww.boehringer-ingelheim.com%2Fanimal-health%2Fanimals-we-support%2Fswine%2Fbiosecurity-swine-prrs-and-asf "Read more"/index.html)

Since 1994, when Boehringer Ingelheim launched the first vaccine against porcine reproductive and respiratory syndrome (PRRS), we have led the industry in fighting this worldwide pig health concern.

Explore the latest research, expert perspectives, actionable tools, and more to help swine producers stay ahead of PRRS.

There are no quick fixes to most of the enteric, respiratory, and reproductive pathogens that erode swine producers’ profitability. Investing in preventive care—from a comprehensive herd vaccination program to surveillance and biosecurity—brings measurable returns in pig health and productivity as well as business sustainability. Boehringer’s swine experts have the data to prove it.

Rapid response against serious swine disease outbreaks

Learn how Boehringer Ingelheim’s Veterinary Public Health (VPH) experts monitor, prepare for, and deploy against highly transmissible animal diseases like foot-and-mouth disease that threaten swine health, economic systems, and global food supply.

[More on transboundary diseases](/content/za/animal-health/veterinary-public-health "More on transboundary diseases"/index.html)

Collaboration on swine vaccine innovation

Boehringer has built longstanding partnerships with world-class research institutes to bring critical vaccines to market faster.

References